| A single center observational study of the clinical characteristics and short-term outcome of 20 kidney transplant patients admitted for SARS-CoV2 pneumonia F Alberici, E Delbarba, C Manenti, L Econimo, F Valerio, A Pola, C Maffei, ... Kidney international 97 (6), 1083-1088, 2020 | 428 | 2020 |
| Management of patients on dialysis and with kidney transplantation during the SARS-CoV-2 (COVID-19) pandemic in Brescia, Italy F Alberici, E Delbarba, C Manenti, L Econimo, F Valerio, A Pola, C Maffei, ... Kidney International Reports 5 (5), 580-585, 2020 | 335 | 2020 |
| Rituximab-associated hypogammaglobulinemia: incidence, predictors and outcomes in patients with multi-system autoimmune disease DM Roberts, RB Jones, RM Smith, F Alberici, DS Kumaratne, S Burns, ... Journal of autoimmunity 57, 60-65, 2015 | 321 | 2015 |
| A report from the Brescia Renal COVID Task Force on the clinical characteristics and short-term outcome of hemodialysis patients with SARS-CoV-2 infection F Alberici, E Delbarba, C Manenti, L Econimo, F Valerio, A Pola, C Maffei, ... Kidney international 98 (1), 20-26, 2020 | 289 | 2020 |
| Prednisone versus tamoxifen in patients with idiopathic retroperitoneal fibrosis: an open-label randomised controlled trial A Vaglio, A Palmisano, F Alberici, U Maggiore, S Ferretti, R Cobelli, ... The Lancet 378 (9788), 338-346, 2011 | 272 | 2011 |
| Genome-wide association study of eosinophilic granulomatosis with polyangiitis reveals genomic loci stratified by ANCA status PA Lyons, JE Peters, F Alberici, J Liley, RMR Coulson, W Astle, C Baldini, ... Nature communications 10 (1), 5120, 2019 | 219 | 2019 |
| IgG4 immune response in Churg–Strauss syndrome A Vaglio, JD Strehl, B Manger, F Maritati, F Alberici, C Beyer, J Rech, ... Annals of the Rheumatic Diseases 71 (3), 390-393, 2012 | 212 | 2012 |
| Long-term follow-up of patients who received repeat-dose rituximab as maintenance therapy for ANCA-associated vasculitis F Alberici, RM Smith, RB Jones, DM Roberts, LC Willcocks, A Chaudhry, ... Rheumatology 54 (7), 1153-1160, 2015 | 153 | 2015 |
| A cross-sectional study of the Birmingham Vasculitis Activity Score version 3 in systemic vasculitis R Suppiah, C Mukhtyar, O Flossmann, F Alberici, B Baslund, R Batra, ... Rheumatology 50 (5), 899-905, 2011 | 140 | 2011 |
| Rituximab or cyclophosphamide in the treatment of membranous nephropathy: the RI-CYCLO randomized trial F Scolari, E Delbarba, D Santoro, L Gesualdo, A Pani, N Dallera, LY Mani, ... Journal of the American Society of Nephrology 32 (4), 972-982, 2021 | 136 | 2021 |
| Trimethoprim–sulfamethoxazole prophylaxis prevents severe/life-threatening infections following rituximab in antineutrophil cytoplasm antibody-associated vasculitis A Kronbichler, J Kerschbaum, S Gopaluni, J Tieu, F Alberici, RB Jones, ... Annals of the rheumatic diseases 77 (10), 1440-1447, 2018 | 122 | 2018 |
| Kidney transplant patients with SARS‐CoV‐2 infection: the brescia renal COVID task force experience N Bossini, F Alberici, E Delbarba, F Valerio, C Manenti, S Possenti, ... American Journal of Transplantation 20 (11), 3019-3029, 2020 | 106 | 2020 |
| Mepolizumab for eosinophilic granulomatosis with polyangiitis: a European multicenter observational study A Bettiol, ML Urban, L Dagna, V Cottin, F Franceschini, S Del Giacco, ... Arthritis & rheumatology 74 (2), 295-306, 2022 | 104 | 2022 |
| Immunoglobulin G replacement for the treatment of infective complications of rituximab-associated hypogammaglobulinemia in autoimmune disease: a case series DM Roberts, RB Jones, RM Smith, F Alberici, DS Kumaratne, S Burns, ... Journal of autoimmunity 57, 24-29, 2015 | 88 | 2015 |
| Sirolimus plus prednisone for Erdheim-Chester disease: an open-label trial D Gianfreda, M Nicastro, M Galetti, F Alberici, D Corradi, G Becchi, ... Blood, The Journal of the American Society of Hematology 126 (10), 1163-1171, 2015 | 86 | 2015 |
| Adjuvant low-dose interleukin-2 (IL-2) plus interferon-α (IFN-α) in operable renal cell carcinoma (RCC): a phase III, randomized, multicentre trial of the Italian Oncology … R Passalacqua, C Caminiti, S Buti, C Porta, R Camisa, L Braglia, ... Journal of Immunotherapy 37 (9), 440-447, 2014 | 86 | 2014 |
| Lack of EULAR/ERA-EDTA response at 1 year predicts poor long-term renal outcome in patients with lupus nephritis G Moroni, M Gatto, F Tamborini, S Quaglini, F Radice, F Saccon, ... Annals of the Rheumatic Diseases 79 (8), 1077-1083, 2020 | 74 | 2020 |
| Methotrexate plus prednisone in patients with relapsing idiopathic retroperitoneal fibrosis F Alberici, A Palmisano, ML Urban, F Maritati, E Oliva, L Manenti, ... Annals of the rheumatic diseases 72 (9), 1584-1586, 2013 | 73 | 2013 |
| PTPN22 R620W polymorphism in the ANCA-associated vasculitides D Martorana, F Maritati, G Malerba, F Bonatti, F Alberici, E Oliva, ... Rheumatology 51 (5), 805-812, 2012 | 70 | 2012 |
| Measurement of damage in systemic vasculitis: a comparison of the Vasculitis Damage Index with the Combined Damage Assessment Index R Suppiah, O Flossman, C Mukhtyar, F Alberici, B Baslund, D Brown, ... Annals of the rheumatic diseases 70 (1), 80-85, 2011 | 62 | 2011 |
